January 19, 2022 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fi…
January 19, 2022 Comments Off on Drug Patent Expirations for the Week of January 16, 2022 Posted in: Uncategorized
ALPHAGAN P (brimonidine tartrate) Allergan Patent: 6,627,210 Expiration: Jan 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
